RANI Rani Therapeutics Holdings, Inc.

NASDAQ
$0.76

Rani Therapeutics Holdings, Inc. (RANI) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with RANI's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 2 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
2
3 transactions
Insiders selling
2
3 transactions
Purchases
$1.3M
2,154,334 shares
Sales
$15.7M
5,923,386 shares
Net activity
-$14.4M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $15.7M 3 transactions · 5,923,386 shares

Largest single sale: $11.1M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: July 21, 2026 , by IMRAN MIR A .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
IMRAN MIR A Director Buy 36,000 $0.69 $24.8K 2,119,334
Imran Talat Chief Executive Officer Buy 35,000 $0.72 $25.2K 469,736
Javadi Alireza Chief Technical Officer Sell 386 $0.78 $301 9,689 −3.8% of holding
IMRAN MIR A Director Buy 2,083,334 $0.60 $1.3M 2,083,334
South Cone Investments Limited Partnership 10% Owner Sell 4,000,000 $2.77 $11.1M 2,379,194 −62.7% of holding
South Cone Investments Limited Partnership 10% Owner Sell 1,923,000 $2.41 $4.6M 6,379,194 −23.2% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.